Gujarat Terce Laboratories Limited (BOM:524314)

India flag India · Delayed Price · Currency is INR
57.75
+3.11 (5.69%)
At close: Jun 13, 2025
21.71%
Market Cap 421.84M
Revenue (ttm) 501.95M
Net Income (ttm) -9.79M
Shares Out 7.42M
EPS (ttm) -1.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,496
Average Volume 6,978
Open 55.90
Previous Close 54.64
Day's Range 55.89 - 60.01
52-Week Range 44.52 - 94.90
Beta 0.62
RSI 51.60
Earnings Date May 28, 2025

About BOM:524314

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company’s products include branded generic pharmaceutical covering various therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides its products in various forms, including tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, and Aziter brands. Gujarat Ter... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 286
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524314
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.